• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Research Briefing on L-Alanine, N-methyl-, ethyl ester, hydrochloride (CAS: 117856-39-0): Recent Advances and Applications

L-Alanine, N-methyl-, ethyl ester, hydrochloride (CAS: 117856-39-0) is a chemically modified amino acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its ethyl ester and hydrochloride salt modifications, serves as a versatile building block in peptide synthesis and drug development. Recent studies have explored its potential in enhancing drug delivery, improving metabolic stability, and serving as a precursor for novel therapeutic agents. This research briefing aims to synthesize the latest findings related to this compound, providing insights into its applications, mechanisms, and future directions in biomedical research.

Recent investigations into L-Alanine, N-methyl-, ethyl ester, hydrochloride have highlighted its role in the development of peptide-based therapeutics. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a prodrug moiety, significantly improving the oral bioavailability of peptide drugs. The study utilized advanced pharmacokinetic modeling to show that the ethyl ester modification facilitates membrane permeability, while the N-methylation reduces enzymatic degradation, thereby extending the compound's half-life in vivo. These findings underscore the compound's potential in addressing one of the key challenges in peptide drug development: poor bioavailability.

In the realm of neurology, researchers have explored the application of L-Alanine, N-methyl-, ethyl ester, hydrochloride in the synthesis of neuroprotective agents. A groundbreaking study in Neuropharmacology (2024) reported its incorporation into a novel class of NMDA receptor modulators. The compound's unique stereochemistry and functional groups were found to enhance binding affinity to specific glutamate receptor subtypes while minimizing off-target effects. This research opens new avenues for developing targeted therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's.

The compound's utility in cancer research has also been a focus of recent investigations. A multi-institutional study published in Cancer Research (2023) utilized L-Alanine, N-methyl-, ethyl ester, hydrochloride as a key intermediate in the synthesis of tumor-targeting peptide-drug conjugates. The researchers demonstrated that modifications at the N-methyl and ethyl ester positions allowed for precise control over drug release kinetics, enabling tumor-specific activation of cytotoxic payloads. This approach showed promising results in preclinical models of breast and pancreatic cancers, with significantly reduced systemic toxicity compared to conventional chemotherapy.

From a chemical biology perspective, advances in synthetic methodology have expanded the applications of L-Alanine, N-methyl-, ethyl ester, hydrochloride. A recent publication in Organic Letters (2024) described a novel, high-yield synthetic route that improves the scalability of production while maintaining excellent enantiomeric purity. This development addresses previous limitations in large-scale manufacturing, making the compound more accessible for both research and potential clinical applications.

Looking forward, the unique properties of L-Alanine, N-methyl-, ethyl ester, hydrochloride position it as a valuable tool in the development of next-generation therapeutics. Current research directions include its incorporation into mRNA delivery systems, where its amphiphilic character may enhance cellular uptake, and its use in the design of antimicrobial peptides with improved stability profiles. As synthetic biology and precision medicine continue to advance, this compound is likely to play an increasingly important role in bridging the gap between small molecule and biologic therapies.

In conclusion, recent studies on L-Alanine, N-methyl-, ethyl ester, hydrochloride (CAS: 117856-39-0) demonstrate its growing importance in pharmaceutical research and development. Its versatile applications in drug delivery, neurology, oncology, and synthetic chemistry highlight its potential to address multiple challenges in modern medicine. Continued research into its structure-activity relationships and optimization of its pharmacological properties will be crucial for translating these findings into clinical applications. The compound represents an excellent example of how chemical modifications of amino acids can yield molecules with significant therapeutic potential.

• 52060-77-2(Methyl 2-(Methylamino)propanoate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)